Sign up to save your podcasts
Or
Share In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
We love to hear from our listeners. Send us a message.
Umoja Biopharma's CEO, Andy Scharenberg, M.D., joins Cell & Gene: The Podcast's Erin Harris to discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics. They discuss The Climb, or The Colorado Laboratory and Innovation Manufacturing Building, which is Umoja’s lentiviral vector development and manufacturing facility. They also cover recent progress in lentiviral vector manufacturing.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Umoja Biopharma's CEO, Andy Scharenberg, M.D., joins Cell & Gene: The Podcast's Erin Harris to discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics. They discuss The Climb, or The Colorado Laboratory and Innovation Manufacturing Building, which is Umoja’s lentiviral vector development and manufacturing facility. They also cover recent progress in lentiviral vector manufacturing.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
765 Listeners
Science Magazine Podcast
807 Listeners
Economist Podcasts
4,246 Listeners
Freakonomics Radio
32,043 Listeners
The Long Run with Luke Timmerman
124 Listeners
Immune
271 Listeners
The Readout Loud
318 Listeners
FT News Briefing
699 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
147 Listeners
Biotech Hangout
11 Listeners
ASGCT Podcast Network
15 Listeners
Elon, Inc.
149 Listeners
Ground Truths
47 Listeners